Jürgen Raths
Corporate Officer/Principal bei Executive Insight AG
Profil
Jürgen Raths currently works at Executive Insight AG, as Associate Partner from 2015.
Dr. Raths also formerly worked at Arpida AG, as President & Chief Executive Officer in 2009, Advanz Pharma Switzerland SARL, as President & Chief Executive Officer from 2010 to 2013, Vesselon, Inc., as Director, PAION AG, as Chief Operating Officer from 2015 to 2017, and Eli Lilly (Suisse) SA, as Head-Critical Care Europe from 1990 to 2008.
Dr. Raths received his doctorate degree from the University of Bonn.
Aktive Positionen von Jürgen Raths
Unternehmen | Position | Beginn |
---|---|---|
Executive Insight AG | Corporate Officer/Principal | 01.01.2015 |
Ehemalige bekannte Positionen von Jürgen Raths
Unternehmen | Position | Ende |
---|---|---|
PAION AG | Geschäftsführer | 01.03.2017 |
Advanz Pharma Switzerland SARL
Advanz Pharma Switzerland SARL Pharmaceuticals: MajorHealth Technology Advanz Pharma Switzerland SARL manufactures and wholesales pharmaceuticals. The company is headquartered in Geneva, Switzerland. | Vorstandsvorsitzender | 01.01.2013 |
Arpida AG
Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Präsident | 14.12.2009 |
Eli Lilly (Suisse) SA | Corporate Officer/Principal | 01.01.2008 |
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Direktor/Vorstandsmitglied | - |
Ausbildung von Jürgen Raths
University of Bonn | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PAION AG | Health Technology |
Private Unternehmen | 5 |
---|---|
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Health Technology |
Arpida AG
Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Health Technology |
Eli Lilly (Suisse) SA | |
Advanz Pharma Switzerland SARL
Advanz Pharma Switzerland SARL Pharmaceuticals: MajorHealth Technology Advanz Pharma Switzerland SARL manufactures and wholesales pharmaceuticals. The company is headquartered in Geneva, Switzerland. | Health Technology |
Executive Insight AG |